Reslizumab (RES) in patients (pts) with inadequately controlled asthma and elevated blood eosinophils (EOS): Analysis of two phase 3, placebo-controlled trials

  • Johann Christian Virchow, James Zangrilli, Sivan Weiss, Stephanie Korn
  • European Respiratory Journal, September 2016, European Respiratory Society (ERS)
  • DOI: 10.1183/13993003.congress-2016.oa1797

The authors haven't yet claimed this publication.

Read Publication

In partnership with:

Link to European Respiratory Society (ERS) showcase